Cargando…

O-Aryl-Glycoside Ice Recrystallization Inhibitors as Novel Cryoprotectants: A Structure–Function Study

[Image: see text] Low-molecular-weight ice recrystallization inhibitors (IRIs) are ideal cryoprotectants that control the growth of ice and mitigate cell damage during freezing. Herein, we describe a detailed study correlating the ice recrystallization inhibition activity and the cryopreservation ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Capicciotti, Chantelle J., Mancini, Ross S., Turner, Tracey R., Koyama, Toshie, Alteen, Matthew G., Doshi, Malay, Inada, Takaaki, Acker, Jason P., Ben, Robert N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2016
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044640/
https://www.ncbi.nlm.nih.gov/pubmed/30023486
http://dx.doi.org/10.1021/acsomega.6b00163
Descripción
Sumario:[Image: see text] Low-molecular-weight ice recrystallization inhibitors (IRIs) are ideal cryoprotectants that control the growth of ice and mitigate cell damage during freezing. Herein, we describe a detailed study correlating the ice recrystallization inhibition activity and the cryopreservation ability with the structure of O-aryl-glycosides. Many effective IRIs are efficient cryoadditives for the freezing of red blood cells (RBCs). One effective cryoadditive did not inhibit ice recrystallization but instead inhibited ice nucleation, demonstrating the significance of inhibiting both processes and illustrating the importance of this emerging class of cryoprotectants.